Best Supplements for Non-Alcoholic Fatty Liver Dis…

Non-alcoholic fatty liver disease (NAFLD) was renamed metabolic dysfunction-associated steatotic liver disease (MASLD) in 2023 to better reflect its metabolic roots. Whatever you call it, roughly 30% of U.S. adults have it, and most do not know. Fat accumulates in liver cells, triggers inflammation, and can progress through fibrosis toward cirrhosis over years to decades.

Lifestyle intervention — weight loss, reduced ultra-processed food intake, and regular exercise — is the single most effective treatment. No supplement replaces that. But for patients who are also making lifestyle changes, several supplements have earned meaningful clinical evidence.

Vitamin E: The Most-Studied Option

Vitamin E at 800 IU/day is the only supplement with biopsy-proven benefit in NASH (non-alcoholic steatohepatitis, the inflammatory form of NAFLD). The landmark PIVENS trial (2010, published in NEJM) showed that vitamin E significantly improved liver histology in non-diabetic NASH patients versus placebo. The FDA has discussed vitamin E as a treatment option based on this data.

The concern: higher-dose vitamin E (above 400 IU/day) has been associated in some meta-analyses with modestly increased all-cause mortality and prostate cancer risk (SELECT trial). Most hepatologists weigh this carefully and typically recommend vitamin E for confirmed NASH, not simple hepatic steatosis, and with regular monitoring.

Omega-3 Fatty Acids

High-dose omega-3 fatty acids (3-4g/day of EPA+DHA) consistently reduce hepatic triglyceride content in randomized controlled trials. A 2016 meta-analysis in Journal of Hepatology found omega-3 supplementation significantly reduced liver fat and ALT levels across 10 RCTs. The effect on liver fibrosis and histological NASH is less clear, but the lipid-lowering benefit alone is clinically meaningful for NAFLD patients who frequently have concurrent dyslipidemia.

Berberine

Berberine (500mg two to three times daily with meals) activates AMPK, improves insulin sensitivity, and has shown impressive results in NAFLD trials. A 2015 RCT found berberine reduced liver fat assessed by ultrasound and improved liver enzymes over 16 weeks. Berberine also reduces fasting glucose, HbA1c, and LDL cholesterol, making it particularly attractive for NAFLD patients with metabolic syndrome. GI side effects (bloating, loose stool) are common at initiation but usually improve within two weeks.

Silymarin (Milk Thistle)

Silymarin at 420-600mg/day has antioxidant and anti-inflammatory effects in liver tissue. Multiple small RCTs show modest reductions in ALT and AST in NAFLD patients. The evidence is less robust than vitamin E or omega-3, but the safety profile is excellent and it is often used as an adjunct. The SILIVER trial found silymarin-phospholipid complex reduced liver fat on MRI over 6 months.

Curcumin

Curcumin (bioavailable forms: 500-1,000mg/day of phytosome or nanoparticle formulations) has shown reductions in liver fat, ALT, and inflammatory markers in several small RCTs. Poor bioavailability is the primary limitation of standard curcumin — bioavailable preparations (BCM-95, Meriva, or nanoparticle forms) are necessary for any clinical effect.

Resveratrol

Resveratrol activates SIRT1 and AMPK pathways involved in fat metabolism. Human trials in NAFLD show modest improvements in liver enzymes and insulin sensitivity at 500-2,000mg/day. The data is promising but less consistent than berberine or omega-3.

Choline Deficiency and NAFLD

Choline deficiency is directly implicated in fatty liver development. Choline is required to synthesize VLDL particles that export fat from the liver. Without adequate choline, triglycerides accumulate. Adequate intake is 425mg/day for women and 550mg/day for men. Vegans, people who avoid eggs, and women with PEMT gene variants are at elevated risk. Supplementing with CDP-choline or alpha-GPC can be useful if dietary choline is low.

TUDCA

TUDCA (500-1,000mg/day) reduces ER stress in hepatocytes and has shown liver enzyme improvements in NAFLD RCTs. It is expensive but provides a mechanism distinct from antioxidant or metabolic approaches.

Monitoring: FibroScan and Lab Work

If you have NAFLD, track progress with liver enzyme panels (ALT, AST, GGT) every 3-6 months and consider FibroScan (liver stiffness measurement) annually to monitor fibrosis. Supplements may improve enzymes without reversing fibrosis, so objective monitoring matters.

Working With a Hepatologist

If your NAFLD has progressed to NASH or fibrosis (F2 or above on FibroScan), work with a gastroenterologist or hepatologist. New FDA-approved treatments (resmetirom/Rezdiffra for NASH with fibrosis) are now available and represent a meaningful advance over supplements alone.

The bottom line

Vitamin E, omega-3, and berberine have the strongest clinical evidence for NAFLD; silymarin, curcumin, and TUDCA offer solid adjunct support with excellent safety profiles, but none replace the metabolic lifestyle changes that drive the most durable results.

Managing NAFLD requires tracking what you take and when. Use Optimize free.

Best Supplements for Non-Alcoholic Fatty Liver Disease (NAFLD)